Mandate

EQT sells HemoCue to Quest Diagnostics Inc.

February 19, 2007

EQT has signed an agreement with Quest Diagnostics Inc. regarding the sale of HemoCue. HemoCue AB develops, manufactures and markets diagnostic systems for decentralized analyses at doctors' offices, health centres, hospital reception areas and various hospital wards.

Vinge acted as advisor to EQT during the sale. Representatives from Vinge included Fredrik von Baumgarten, Tuula Tallavaara, Ulrich Ziche, Fredrik von der Esch and Louis de Geer.

Related

Vinge has advised Nordion Energi AB in connection with the acquisition of shares in Kalmar Energi

Nordion Energi acquires E.ON Sverige AB’s entire stake in Kalmar Energi and in connection with the completion of such, divest Kalmar Energi’s electricity retail business to Siljansvik AB (publ).
May 29, 2026

Vinge advises Latour on the sale of shares in ASSA ABLOY and Securitas, amounting to SEK 2.5 billion in each company

Vinge has advised Investmentaktiebolaget Latour (publ) in connection with the sale of parts of its shareholdings in ASSA ABLOY and Securitas for a total value of SEK 5 billion.
May 27, 2026

Vinge advises Hybridge Group on the acquisition of NESC

Hybridge Group and the consultancy firm NESC are merging. Through the merger, Hybridge Group is strengthening its offering in the field of prefabricated structural solutions.
May 27, 2026